Churchill Capital Corp XII

Aktienanalyse zu Churchill Capital Corp XII (CXII)

$10.350

0.000 (0.00%)Zum Schluss

Loading chart…
Hoch
10.400
Eröffnung
10.400
Volumengewichteter Durchschnittskurs
10.37
Volumen
935.00
Marktkap.
—
Tief
10.350
Umsatz
9.69K
EV/EBITDA, TTM
0.00

Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue.

KI-Analyse of Churchill Capital Corp XII (CXII)

Halten

Currently, CXII is not a strong buy due to its low RSI of 12.625, indicating it is oversold, and a high P/E ratio of 258.50, which suggests it may be overvalued. However, the recent positive net income of 2,282,907 USD in Q2 2026 shows potential for recovery. The main risk is the current ratio of 12.07, which is high, but the previous quarter's current ratio was only 0.04, indicating a significant improvement in liquidity. Therefore, while there are signs of recovery, the high valuation and low momentum suggest holding off on buying for now.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Churchill Capital Corp XII (CXII) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

Whales, die CXII halten

M

Magnetar Capital Partners, LP

+ HältCXII

+0.18%

3-Monats-Rendite

CXII FAQ – beantwortet von Alphio AI

Churchill Capital Corp XII is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has conducted no operations and has generated no revenue. It operates in the Financials sector.

Currently, CXII is not a strong buy due to its low RSI of 12.625, indicating it is oversold, and a high P/E ratio of 258.50, which suggests it may be overvalued. However, the recent positive net income of 2,282,907 USD in Q2 2026 shows potential for recovery. The main risk is the current ratio of 12.07, which is high, but the previous quarter's current ratio was only 0.04, indicating a significant improvement in liquidity. Therefore, while there are signs of recovery, the high valuation and low momentum suggest holding off on buying for now.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln